Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Christiane J. Bruns
ResearcherPublications, citations & collaboration network
Christiane J. Bruns is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 1,074 works, 25,945 citations, an h-index of 80 and an i10-index of 340.
1,074
Works
25,945
Citations
80
h-index
340
i10-index
How has Christiane J. Bruns's publication output changed over time?
ScholarIQpublication output · 1999–2021
Output grew100% over the shown period — from 1 works in 1999 to 2 in 2021.
1
2
1
1
1
1
1
1
1
2
1999200020022007200920112014201520202021
What are the most-cited papers on Christiane J. Bruns?
ScholarIQmost cited works
Distinct Populations of Cancer Stem Cells Determine Tumor Growth and Metastatic Activity in Human Pancreatic Cancer
Patrick Hermann, Stephan Huber, Tanja Herrler, Alexandra Aicher, Joachim W. Ellwart, Markus Guba, Christiane J. Bruns, Christopher Heeschen
S128124174. 20072,930 CitationsOPEN ACCESS
Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor
Markus Guba, Philipp von Breitenbuch, Markus Steinbauer, Gudrun E. Koehl, Stefanie Flegel, Matthias Hornung, Christiane J. Bruns, Carl Zuelke, Stefan Farkas, Matthias Anthuber, Karl‐Walter Jauch, Edward K. Geissler
Nature Medicine. 20021,738 Citations
Efficacy of stapler versus hand-sewn closure after distal pancreatectomy (DISPACT): a randomised, controlled multicentre trial
Markus K. Diener, Christoph M. Seiler, Inga Rossion, Jörg Kleeff, Matthias Glanemann, Giovanni Butturini, Aleš Tomažič, Christiane J. Bruns, Olivier R. Busch, Stefan Farkas, Orlin Belyaev, John P. Neoptolemos, Christopher Halloran, Tobias Keck, Marco Niedergethmann, Klaus Gellert, Helmut Witzigmann, Otto Kollmar, Peter Langer, Ulrich Steger, Jens Neudecker, Frederik Berrevoet, Silke Ganzera, M. M. Heiss, Steffen Luntz, Thomas Brückner, Meinhard Kieser, Markus W. Büchler
The Lancet. 2011557 Citations
Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma.
Christiane J. Bruns, Carmen C. Solórzano, Matthew T. Harbison, Shutaro Ozawa, Rachel Tsan, Dominic Fan, James L. Abbruzzese, Peter Traxler, Elisabeth Buchdunger, Robert Radinsky, Isaiah J. Fidler
PubMed. 2000501 Citations
Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms.
Christiane J. Bruns, Matthew T. Harbison, Darren W. Davis, Charles A. Portera, Rachel Tsan, David J. McConkey, Douglas B. Evans, James L. Abbruzzese, Daniel J. Hicklin, Robert Radinsky
PubMed. 2000423 Citations
Related on ScholarIQ
Klinik und Poliklinik für Psychosomatik und Psychotherapie
Institution
Distinct Populations of Cancer Stem Cells Determine Tumor Growth and Metastatic Activity in Human Pancreatic Cancer
Paper
Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor
Paper
Efficacy of stapler versus hand-sewn closure after distal pancreatectomy (DISPACT): a randomised, controlled multicentre trial
Paper
Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma.
Paper
Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms.
Paper